Terms: = Lung cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Staging
5 results:
1. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
2. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Raz DJ; Ray MR; Kim JY; He B; Taron M; Skrzypski M; Segal M; Gandara DR; Rosell R; Jablons DM
Clin Cancer Res; 2008 Sep; 14(17):5565-70. PubMed ID: 18765549
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers.
Lam DC; Girard L; Suen WS; Chung LP; Tin VP; Lam WK; Minna JD; Wong MP
J Thorac Oncol; 2006 Nov; 1(9):932-42. PubMed ID: 17409975
[TBL] [Abstract] [Full Text] [Related]
4. A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract] [Full Text] [Related]
